Aurobindo Pharma Shows Resilience Amid Market Volatility and Sector Gains

Aurobindo Pharma has shown significant activity today, gaining 5.77% as of April 3, 2025. The stock has outperformed its sector, which rose by 2.92%, and has recorded a consecutive gain over the last two days, accumulating a total return of 8.64% during this period. Notably, Aurobindo Pharma opened with a gap up of 6.98% and reached an intraday high of Rs 1267.95, reflecting a peak increase of 9.21%.
The stock has exhibited high volatility today, with an intraday volatility rate of 116.96%. In terms of moving averages, Aurobindo Pharma's current price is above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average.

In the broader market context, the Sensex experienced a recovery after a significant gap down opening, currently trading at 76,292.50, down 0.42%. Aurobindo Pharma's performance over various time frames indicates resilience, with a year-to-date decline of 7.91% compared to the Sensex's 2.36% drop. Over the past three years, the stock has surged by 80.27%, significantly outperforming the Sensex's 28.71% increase.